spacer
spacer

PDBsum entry 2aeb

Go to PDB code: 
protein ligands metals links
Hydrolase/hydrolase inhibitor PDB id
2aeb

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
314 a.a. *
Ligands
ABH ×2
Metals
_MN ×4
Waters ×384
* Residue conservation analysis
PDB id:
2aeb
Name: Hydrolase/hydrolase inhibitor
Title: Crystal structure of human arginase i at 1.29 a resolution and exploration of inhibition in immune response.
Structure: Arginase 1. Chain: a, b. Synonym: liver-type arginase. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562
Biol. unit: Trimer (from PDB file)
Resolution:
1.29Å     R-factor:   0.165     R-free:   0.179
Authors: L.Di Costanzo,G.Sabio,A.Mora,P.C.Rodriguez,A.C.Ochoa,F.Centeno, D.W.Christianson
Key ref:
L.Di Costanzo et al. (2005). Crystal structure of human arginase I at 1.29-A resolution and exploration of inhibition in the immune response. Proc Natl Acad Sci U S A, 102, 13058-13063. PubMed id: 16141327 DOI: 10.1073/pnas.0504027102
Date:
21-Jul-05     Release date:   06-Sep-05    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P05089  (ARGI1_HUMAN) -  Arginase-1 from Homo sapiens
Seq:
Struc:
322 a.a.
314 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.3.5.3.1  - arginase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

      Pathway:
Urea Cycle and Arginine Biosynthesis
      Reaction: L-arginine + H2O = urea + L-ornithine
L-arginine
+ H2O
=
urea
Bound ligand (Het Group name = ABH)
matches with 57.14% similarity
+ L-ornithine
      Cofactor: Mn(2+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1073/pnas.0504027102 Proc Natl Acad Sci U S A 102:13058-13063 (2005)
PubMed id: 16141327  
 
 
Crystal structure of human arginase I at 1.29-A resolution and exploration of inhibition in the immune response.
L.Di Costanzo, G.Sabio, A.Mora, P.C.Rodriguez, A.C.Ochoa, F.Centeno, D.W.Christianson.
 
  ABSTRACT  
 
Human arginase I is a potential target for therapeutic intervention in diseases linked to compromised l-arginine homeostasis. Here, we report high-affinity binding of the reaction coordinate analogue inhibitors 2(S)-amino-6-boronohexanoic acid (ABH, Kd = 5 nM) and S-(2-boronoethyl)-l-cysteine (BEC, Kd = 270 nM) to human arginase I, and we report x-ray crystal structures of the respective enzyme-inhibitor complexes at 1.29- and 1.94-A resolution determined from crystals twinned by hemihedry. The ultrahigh-resolution structure of the human arginase I-ABH complex yields an unprecedented view of the binuclear manganese cluster and illuminates the structural basis for nanomolar affinity: bidentate inner-sphere boronate-manganese coordination interactions and fully saturated hydrogen bond networks with inhibitor alpha-amino and alpha-carboxylate groups. These interactions are therefore implicated in the stabilization of the transition state for l-arginine hydrolysis. Electron density maps also reveal that active-site residue H141 is protonated as the imidazolium cation. The location of H141 is such that it could function as a general acid to protonate the leaving amino group of l-ornithine during catalysis, and this is a revised mechanistic proposal for arginase. This work serves as a foundation for studying the structural and chemical biology of arginase I in the immune response, and we demonstrate the inhibition of arginase activity by ABH in human and murine myeloid cells.
 
  Selected figure(s)  
 
Figure 2.
Fig. 2. Mechanism of human arginase I. New features suggested by the 1.29-Å resolution structure of the complex with ABH are the inner-sphere coordination of 2-NH[2] to in the tetrahedral intermediate, and the protonation of the amino leaving group of L-ornithine by the conformationally flexible imidazolium group of general acid H141. D128 may also donate a proton to L-ornithine before product release. In the final step of catalysis, the H141 imidazole may serve as a general base to abstract a proton from the metal-bridging water molecule (possibly through an intervening solvent molecule). For clarity, only the side chain guanidinium group of substrate L-arginine and the side chain amino group of product L-ornithine are indicated.
Figure 4.
Fig. 4. Arginase I-ABH complexes. Summary of average intermolecular interactions in the human arginase I-ABH complex (gray numbers) and the rat arginase I-ABH complex (orange numbers). Note that the higher resolution of the human arginase I-ABH structure allows for more accurate hydrogen bond distance measurements. Manganese coordination interactions are indicated by green dashed lines, and hydrogen bonds are indicated by black dashed lines. Several slightly shorter and stronger enzyme-inhibitor hydrogen bond interactions are observed in the human enzyme, consistent with its enhanced affinity for ABH (Table 2).
 
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21232540 E.Riley, S.C.Roberts, and B.Ullman (2011).
Inhibition profile of Leishmania mexicana arginase reveals differences with human arginase I.
  Int J Parasitol, 41, 545-552.  
20226211 D.Schade, J.Kotthaus, and B.Clement (2010).
Modulating the NO generating system from a medicinal chemistry perspective: current trends and therapeutic options in cardiovascular disease.
  Pharmacol Ther, 126, 279-300.  
20153713 L.Di Costanzo, M.Ilies, K.J.Thorn, and D.W.Christianson (2010).
Inhibition of human arginase I by substrate and product analogues.
  Arch Biochem Biophys, 496, 101-108.
PDB codes: 3kv2 3lp4 3lp7
19093830 E.Y.Shishova, L.Di Costanzo, F.A.Emig, D.E.Ash, and D.W.Christianson (2009).
Probing the specificity determinants of amino acid recognition by arginase.
  Biochemistry, 48, 121-131.
PDB codes: 3e6k 3e6v 3e8q 3e8z 3e9b
19456858 G.A.Wells, I.B.Müller, C.Wrenger, and A.I.Louw (2009).
The activity of Plasmodium falciparum arginase is mediated by a novel inter-monomer salt-bridge between Glu295-Arg404.
  FEBS J, 276, 3517-3530.  
  19661445 J.H.Kim, L.J.Bugaj, Y.J.Oh, T.J.Bivalacqua, S.Ryoo, K.G.Soucy, L.Santhanam, A.Webb, A.Camara, G.Sikka, D.Nyhan, A.A.Shoukas, M.Ilies, D.W.Christianson, H.C.Champion, and D.E.Berkowitz (2009).
Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats.
  J Appl Physiol, 107, 1249-1257.  
18723022 J.M.Fitzpatrick, J.M.Fuentes, I.W.Chalmers, T.A.Wynn, M.Modolell, K.F.Hoffmann, and M.Hesse (2009).
Schistosoma mansoni arginase shares functional similarities with human orthologs but depends upon disulphide bridges for enzymatic activity.
  Int J Parasitol, 39, 267-279.  
19764983 M.Munder (2009).
Arginase: an emerging key player in the mammalian immune system.
  Br J Pharmacol, 158, 638-651.  
19535341 V.Sauvé, P.Roversi, K.J.Leath, E.F.Garman, R.Antrobus, S.M.Lea, and B.C.Berks (2009).
Mechanism for the hydrolysis of a sulfur-sulfur bond based on the crystal structure of the thiosulfohydrolase SoxB.
  J Biol Chem, 284, 21707-21718.
PDB codes: 2wdc 2wdd 2wde 2wdf
19575800 X.Y.Fan, A.van den Berg, M.Snoek, L.G.van der Flier, B.Smids, H.M.Jansen, R.Y.Liu, and R.Lutter (2009).
Arginine deficiency augments inflammatory mediator production by airway epithelial cells in vitro.
  Respir Res, 10, 62.  
17252310 A.Hrabák, T.Bajor, and G.Mészáros (2008).
The inhibitory effect of various indolyl amino acid derivatives on arginase activity in macrophages.
  Amino Acids, 34, 293-300.  
18360740 D.P.Dowling, L.Di Costanzo, H.A.Gennadios, and D.W.Christianson (2008).
Evolution of the arginase fold and functional diversity.
  Cell Mol Life Sci, 65, 2039-2055.  
18978793 K.C.El Kasmi, J.E.Qualls, J.T.Pesce, A.M.Smith, R.W.Thompson, M.Henao-Tamayo, R.J.Basaraba, T.König, U.Schleicher, M.S.Koo, G.Kaplan, K.A.Fitzgerald, E.I.Tuomanen, I.M.Orme, T.D.Kanneganti, C.Bogdan, T.A.Wynn, and P.J.Murray (2008).
Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens.
  Nat Immunol, 9, 1399-1406.  
  18719233 L.Santhanam, D.W.Christianson, D.Nyhan, and D.E.Berkowitz (2008).
Arginase and vascular aging.
  J Appl Physiol, 105, 1632-1642.  
18802628 T.Y.Zakharian, L.Di Costanzo, and D.W.Christianson (2008).
Synthesis of (2S)-2-amino-7,8-epoxyoctanoic acid and structure of its metal-bridging complex with human arginase I.
  Org Biomol Chem, 6, 3240-3243.
PDB code: 3dj8
17469833 L.Di Costanzo, M.E.Pique, and D.W.Christianson (2007).
Crystal structure of human arginase I complexed with thiosemicarbazide reveals an unusual thiocarbonyl mu-sulfide ligand in the binuclear manganese cluster.
  J Am Chem Soc, 129, 6388-6389.
PDB codes: 2pha 2pho 2zav
17562323 L.Di Costanzo, M.Moulin, M.Haertlein, F.Meilleur, and D.W.Christianson (2007).
Expression, purification, assay, and crystal structure of perdeuterated human arginase I.
  Arch Biochem Biophys, 465, 82-89.
PDB code: 2pll
16862192 A.J.Muller, and P.A.Scherle (2006).
Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors.
  Nat Rev Cancer, 6, 613-625.  
16679012 L.Aravind, L.M.Iyer, and E.V.Koonin (2006).
Comparative genomics and structural biology of the molecular innovations of eukaryotes.
  Curr Opin Struct Biol, 16, 409-419.  
16580971 O.Lespinet, and B.Labedan (2006).
Orphan enzymes could be an unexplored reservoir of new drug targets.
  Drug Discov Today, 11, 300-305.  
17212779 R.Alarcón, M.S.Orellana, B.Neira, E.Uribe, J.R.García, and N.Carvajal (2006).
Mutational analysis of substrate recognition by human arginase type I--agmatinase activity of the N130D variant.
  FEBS J, 273, 5625-5631.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer